16:02 Dec 20
NGL Fine - Chem Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
NGL Fine - Chem Ltd.
66/100 High Financial Strength
Quality37/100 Mid Valuation
Valuation48/100 Technically Neutral
TechnicalSWOT
Strength
6
Weakness
2
Opportunity
0
Threat
0
1.26K
Market Cap (Cr)
30.45
PE Ratio
4.50
Price to Book Ratio
65.97
RSI
12.19 %
Net Profit Margin
SWOT
Download Our App On:
